Skip to content

13F-HR filed by Springhill Fund Asset Management (HK) Co Ltd

Springhill Fund Asset Management (HK) Co Ltd filed this 13F-HR for the quarter ended 2024-12-31, filed 2025-02-13, with 17 holding rows worth $61,575,374.

Accession
0001846639-25-000002
Filed
2025-02-13
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2024

A holdings report, 17 entries on the cover page, a total value of $61,575,374 stated on the cover page (in dollars after the unit check, H1), rows summing to $61,575,374 with VALUE read as dollars as filed, 13F file number 028-25005. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
VERONA PHARMA PLC925050106SPONSORED ADS135,452$6,290,391dollars as filed
LEGEND BIOTECH CORP52490G102SPONSORED ADS190,800$6,208,632dollars as filed
CYTOKINETICS INC23282W605COM NEW130,735$6,149,774dollars as filed
ASTRAZENECA PLC SPONSORED ADR046353108ADR76,500$5,012,280dollars as filed
INSMED INC COM PAR $.01457669307Stock69,500$4,798,280dollars as filed
VERA THERAPEUTICS INC92337R101COMMON STOCK109,400$4,626,526dollars as filed
COGENT BIOSCIENCES INC19240Q201COM548,554$4,278,721dollars as filed
AKERO THERAPEUTICS INC00973Y108COM151,200$4,206,384dollars as filed
MERUS N VN5749R100COM83,800$3,523,790dollars as filed
CULLINAN THERAPEUTICS INC230031106COM276,400$3,366,552dollars as filed
DYNE THERAPEUTICS INC COM26818M108Stock131,200$3,091,072dollars as filed
NURIX THERAPEUTICS INC67080M103COMMON STOCK160,500$3,023,820dollars as filed
BRIGHT MINDS BIOSCIENCES INC10919W405COMMON STOCK60,648$2,184,541dollars as filed
BICYCLE THERAPEUTICS PLC-ADR088786108SPONSORED ADS116,400$1,629,600dollars as filed
JANUX THERAPEUTICS INC47103J105COM29,600$1,584,784dollars as filed
ABIVAX SA-00370M103SPONSORED ADS207,600$1,519,632dollars as filed
SOLENO THERAPEUTICS INC834203309COM1,793$80,595dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001846639-25-000002this filing2025-02-13acceptance time not in the bulk data set